Skip to main content
CivicGate

S 3729
Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.

PBM Reporting Transparency Act

To require the Medicare Payment Advisory Commission (MedPAC) submit to Congress two reports on agreements with pharmacy benefit managers with respect to prescription drug plans and MA-PD plans.

Introduced Jan 29, 2026

Latest action (Jan 29, 2026) Read twice and referred to the Committee on Finance.

Policy area
Issues
Healthcare

Summary

  • Requires the Medicare Payment Advisory Commission to report to Congress on agreements between pharmacy benefit managers and Medicare prescription drug plans.
  • The initial report must analyze trends in these agreements, their effects on patient out-of-pocket costs and pharmacy reimbursement, and include recommendations.
  • A second report must be submitted two years later describing how these agreements have changed over time.

AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.

Sponsor (1)

3 cosponsors

Money behind the sponsor

Top reported contributors to Mark R. Warner’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.

  • CAPITAL GROUP $50,000
  • THE BOEING COMPANY $40,000
  • BLACKROCK $32,400
  • APOLLO GLOBAL MANAGEMENT $24,700
  • C3 AI $18,300

Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Mark R. Warner → · Outside spending →

Actions (2)

  1. Jan 29, 2026 Read twice and referred to the Committee on Finance. · senate
  2. Jan 29, 2026 Introduced in Senate

Full text

IN THE SENATE OF THE UNITED STATES

January 29, 2026

Mr. Warner (for himself, Mr. Tillis, Ms. Cortez Masto, and Mr. Marshall) introduced the following bill; which was read twice and referred to the Committee on Finance

A BILL

To require the Medicare Payment Advisory Commission (MedPAC) submit to Congress two reports on agreements with pharmacy benefit managers with respect to prescription drug plans and MA-PD plans.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the “PBM Reporting Transparency Act”.

SEC. 2. MEDPAC REPORTS ON AGREEMENTS WITH PHARMACY BENEFIT MANAGERS WITH RESPECT TO PRESCRIPTION DRUG PLANS AND MA-PD PLANS.

The Medicare Payment Advisory Commission shall submit to Congress the following reports:

(1) Initial report.—Not later than the first March 15 occurring after the date that is 2 years after the date on which the Secretary makes the data available to the Commission, a report regarding agreements with pharmacy benefit managers with respect to prescription drug plans and MA-PD plans. Such report shall include, to the extent practicable—

(A) a description of trends and patterns, including relevant averages, totals, and other figures for the types of information submitted;

(B) an analysis of any differences in agreements and their effects on plan enrollee out-of-pocket spending and average pharmacy reimbursement, and other impacts; and

(C) any recommendations the Commission determines appropriate.

(2) Final report.—Not later than 2 years after the date on which the Commission submits the initial report under paragraph

(1), a report describing any changes with respect to the information described in paragraph (1) over time, together with any recommendations the Commission determines appropriate. <all>

Similar bills (6)

Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.

Comments

Comments

Loading comments…